IBNSINA PHARMA CO |
End-of-day quote
Other stock markets
|
||
| - EGP | - |
|
| 03-03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 02-05 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 36.64B 782M 1.06B | Sales 2025 * | 46.76B 998M 1.36B | Capitalization | 2.39B 50.98M 69.39M |
|---|---|---|---|---|---|
| Net income 2024 * | 417M 8.9M 12.11M | Net income 2025 * | 448M 9.56M 13.01M | EV / Sales 2024 * | 0.16 x |
| Net Debt 2024 * | 3.65B 77.86M 106M | Net Debt 2025 * | 3.44B 73.44M 99.96M | EV / Sales 2025 * | 0.12 x |
| P/E ratio 2024 * |
7.9
x | P/E ratio 2025 * |
5.73
x | Employees | - |
| Yield 2024 * |
2.47% | Yield 2025 * |
2.78% | Free-Float | 61.4% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 00-12-17 | |
| Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 00-12-17 | |
| Chief Executive Officer | - | 00-12-17 | |
| Director/Board Member | - | - |
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Sector
Drug Retailers
| 1st Jan change | Capi. | |
|---|---|---|
| -29.72% | 15.43B | |
| -20.84% | 12.31B | |
| -24.53% | 6.59B | |
| +12.34% | 6.3B | |
| -8.87% | 5.88B | |
| -1.17% | 4.74B | |
| +60.03% | 4.7B | |
| -5.50% | 4.03B | |
| -8.59% | 3.58B |
